Sir Jules Thorn Charitable Trust Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2014
NCT02265809
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now